Search Results

HDx Enabled by Theranova

HDx enabled by Theranova is a new dialysis therapy we are pioneering for patients with end-stage renal disease. The Theranova dialyzer features an innovative membrane, which provides an expanded hemodialysis therapy (HDx).

​Jeanne Mason, Ph.D.

Jeanne Mason, Ph.D. is executive vice president and chief human resources officer.

​Stephen N. Oesterle, M.D.

Stephen N. Oesterle, M.D. has served as a director of Baxter since February 2017.

​Cathy R. Smith

Cathy R. Smith has served as a director of Baxter since July 2017.

​Stacey Eisen

Stacey Eisen is senior vice president, Chief Communications Officer and Corporate Marketing, and president, Baxter Foundation.

Reazur (​Reaz) Rasul

Reazur (​Reaz) Rasul is executive vice president and group president, Healthcare Systems & Technologies. He was appointed to his role leading Healthcare Systems & Technologies in 2023 after serving as president of Front Line Care since 2022. Prior to that, Rasul served as general manager for the Acute Therapies & Medication Delivery businesses. He joined Baxter in 2017.

Brent Shafer

Brent Shafer has served as Baxter's Non-Executive Chair since August 2025 and has served as a director of Baxter since May 2022. Shafer served as lead independent director from April 2023 to February 2025, prior to his appointment as Interim CEO and Chair of the Board from February 2025 to August 2025.

William A. Ampofo II

William A. Ampofo II has served as a director of Baxter since June 2023. 

Gerard (Jerry) Greco, Ph.D.

Gerard (Jerry) Greco, Ph.D., is senior vice president, chief quality officer. Greco joined Baxter in 2023 from Takeda Pharmaceuticals, where he most recently served as the global quality officer, leading all quality and quality compliance for the company. During his 35-plus years in the healthcare industry, he has served in quality roles of increasing responsibility at Teva Pharmaceuticals, Pfizer, Wyeth Pharmaceuticals and Johnson & Johnson.